Patents by Inventor Emily Pace

Emily Pace has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230149379
    Abstract: Provided herein are methods of treatment of AML comprising administering 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide or a stereoisomer or mixture of stereoisomers, pharmaceutically acceptable salt, tautomer, prodrug, solvate, hydrate, co-crystal, clathrate, or polymorph thereof in a combination therapy.
    Type: Application
    Filed: March 12, 2021
    Publication date: May 18, 2023
    Applicant: Celgene Corporation
    Inventors: Tonia J. BUCHHOLZ, Nian GONG, Jinhong FAN, Emily PACE, Daniel W. PIERCE, Michael POURDEHNAD, Tsun-Wen YAO
  • Publication number: 20190030018
    Abstract: Provided herein are formulations and methods of use of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide or a stereoisomer or mixture of stereoisomers, pharmaceutically acceptable salt, tautomer, prodrug, solvate, hydrate, co-crystal, clathrate, or polymorph thereof.
    Type: Application
    Filed: June 29, 2018
    Publication date: January 31, 2019
    Inventors: Tonia J. Buchholz, James Carmichael, Soraya Carrancio, Jinhong Fan, Rajan Gupta, Gang Lu, Kyle MacBeth, Emily Pace, Daniel Pierce, Michael Pourdehnad, Yu Pu, Peng Wang, Naijun Wu, Sheena Yao